Name | (S)-2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenyipropanoic acid |
---|---|
Synonyms |
N-{(2S)-2-[(4-Morpholinylacetyl)amino]-4-phenylbutanoyl}-L-leucyl-L-phenylalanine
Carfilzomib intermediate (S)-2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoic acid L-Phenylalanine, N-[(2S)-2-[[2-(4-morpholinyl)acetyl]amino]-1-oxo-4-phenylbutyl]-L-leucyl- (alphaS)-alpha-[(4-Morpholinylacetyl)amino]benzenebutanoyl-L-leucyl-L-phenylalanine |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 865.6±65.0 °C at 760 mmHg |
Molecular Formula | C31H42N4O6 |
Molecular Weight | 566.688 |
Flash Point | 477.3±34.3 °C |
Exact Mass | 566.310425 |
PSA | 137.07000 |
LogP | 4.90 |
Vapour Pressure | 0.0±0.3 mmHg at 25°C |
Index of Refraction | 1.562 |
~% 868540-16-3 |
Literature: US2005/245435 A1, ; Page/Page column 31-32 ; |